Jennifer Y Chan

Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-beta peptide levels in vivo.

M. Hayden, C. Wellington, Anna Wilkinson, 2007, Journal of lipid research.

An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia

C. Wellington, Anna Wilkinson, M. Oda, 2011, Journal of Lipid Research.

The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease*

M. Hayden, J. Poirier, W. V. Van Nostrand, 2005, Journal of Biological Chemistry.